Orchid Drug Patent Portfolio
Orchid owns 1 orange book drug protected by 2 US patents Given below is the list of Orchid's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11124526 | Crystalline beta-lactamase inhibitor | 07 Nov, 2034 | Active |
| US7687488 | 2-substituted methyl penam derivatives | 03 Dec, 2027 | Active |
Latest Legal Activities on Orchid's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Orchid.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Second letter to regulating agency to determine regulatory review period | 19 Aug, 2025 | US11124526 |
| Second letter to regulating agency to determine regulatory review period | 19 Aug, 2025 | US7687488 |
| Letter from FDA or Dept of Agriculture re PTE application | 12 Aug, 2025 | US7687488 |
| Information Disclosure Statement (IDS) Filed | 12 Aug, 2025 | US11124526 |
| Letter from FDA or Dept of Agriculture re PTE application | 12 Aug, 2025 | US11124526 |
| Information Disclosure Statement (IDS) Filed | 12 Aug, 2025 | US7687488 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 12 Mar, 2025 | US11124526 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 03 Jul, 2024 | US7687488 |
|
Email Notification
Critical
| 03 Jul, 2024 | US7687488 |
| Requirement for information sent under 37 CFR 1.750 | 25 Apr, 2024 | US7687488 |
| Initial letter Re: PTE Application to regulating agency | 25 Apr, 2024 | US7687488 |
| Initial letter Re: PTE Application to regulating agency | 25 Apr, 2024 | US11124526 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 22 Sep, 2021 | US7687488 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 21 Sep, 2021 | US11124526 |
|
Recordation of Patent Grant Mailed
Critical
| 21 Sep, 2021 | US11124526 |
Orchid's Family Patents
Orchid Drug List
Given below is the complete list of Orchid's drugs and the patents protecting them.
1. Exblifep
Exblifep is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11124526 | Crystalline beta-lactamase inhibitor |
07 Nov, 2034
(8 years from now)
| Active |
| US7687488 | 2-substituted methyl penam derivatives |
03 Dec, 2027
(1 year, 8 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Exblifep's drug page